Xoma | XOMA - Ebit

Aktienkurs
37.90
Täglich Wechseln
0.01 0.03%
Monatlich
25.50%
Jährlich
57.00%
Q2 Prognose
37.09




Ebit Veränderung Datum
AbbVie USD 5.81B 4.36B 2025-12
Agenus USD 14.4M 19.26M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
aTyr Pharma USD 24.47M 24.7M 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Curis USD -7.88M 4.31M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Incyte USD 383.88M 47.44M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Novartis USD 4.06B 530M 2025-12
Novartis USD 4.06B 413M 2025-12
Pfizer USD 4.65B 71M 2025-12
Prothena USD -27.21M 12.55M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Xoma USD -10.08M 4.4M 2024-06